Pardes Biosciences Stock Number Of Shares Shorted
PRDSDelisted Stock | USD 2.14 0.01 0.47% |
Pardes Biosciences fundamentals help investors to digest information that contributes to Pardes Biosciences' financial success or failures. It also enables traders to predict the movement of Pardes Stock. The fundamental analysis module provides a way to measure Pardes Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pardes Biosciences stock.
Pardes |
Pardes Biosciences Company Number Of Shares Shorted Analysis
Pardes Biosciences' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Pardes Biosciences Number Of Shares Shorted | 874.35 K |
Most of Pardes Biosciences' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pardes Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Pardes Biosciences has 874.35 K of outstending shares currently sold short by investors. This is 72.67% lower than that of the Biotechnology sector and 82.85% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 81.42% higher than that of the company.
Pardes Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pardes Biosciences' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pardes Biosciences could also be used in its relative valuation, which is a method of valuing Pardes Biosciences by comparing valuation metrics of similar companies.Pardes Biosciences is currently under evaluation in number of shares shorted category among its peers.
Pardes Fundamentals
Return On Equity | -0.4 | |||
Return On Asset | -0.26 | |||
Current Valuation | (22.1 M) | |||
Shares Outstanding | 62.01 M | |||
Shares Owned By Insiders | 13.47 % | |||
Shares Owned By Institutions | 72.05 % | |||
Number Of Shares Shorted | 874.35 K | |||
Price To Book | 0.37 X | |||
EBITDA | (99.82 M) | |||
Net Income | (96.63 M) | |||
Cash And Equivalents | 228.6 M | |||
Cash Per Share | 3.67 X | |||
Current Ratio | 20.84 X | |||
Book Value Per Share | 2.57 X | |||
Cash Flow From Operations | (71.98 M) | |||
Short Ratio | 1.09 X | |||
Earnings Per Share | (1.28) X | |||
Target Price | 1.25 | |||
Number Of Employees | 57 | |||
Beta | 0.42 | |||
Market Capitalization | 133.95 M | |||
Total Asset | 200.62 M | |||
Retained Earnings | (148.16 M) | |||
Working Capital | 179.98 M | |||
Z Score | -1.6 | |||
Net Asset | 200.62 M |
About Pardes Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pardes Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pardes Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pardes Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |